Capital Insights

Recent media items include:

In Law360, IP Litigators Examine Bill Curtailing Patent Troll Lawsuits at ITC (September 17, 2020)
In Law360, Tom Bulleit Examines Trump’s Latest Drug Pricing Executive Order (September 15, 2020)
In Law360, LSRC Attorneys Examine HHS Announcement Barring FDA from Requiring Premarket Review for Laboratory-Developed Tests (September 2, 2020)
In IP Litigator, Attorneys Examine U.S. Supreme Court Copyright and Trademark Cases (August 12, 2020)
In Law360, Health Care Attorneys Examine Drug Pricing Reforms and Value-Based Pricing (August 3, 2020)
In Law360, Health Care Attorneys Examine CMS Proposed Rule for Value-Based Purchasing Arrangements (July 10, 2020)
Ropes & Gray Successfully Defends TCL and Roku in High-Profile Lawsuit Alleging Infringement of TCL Roku Smart TVs (June 26, 2020)
In Law360, Attorneys Analyze Expanded U.S. Government Scrutiny of Research Compliance (June 26, 2020)
In CNBC, Megan Bisk Explores Employer Liability from COVID-19 Workplace Lawsuits (June 22, 2020)
In Bloomberg Law, Scott McKeown Examines Collateral Agreements Under Patent Law (June 17, 2020)
Ropes & Gray Wins Federal Circuit Victory for Sioux Steel Company (June 16, 2020)
In Science Magazine, Valerie Bonham Addresses NIH Challenges to Distribute COVID-19 Pandemic Research Funds (June 4, 2020)
In Bloomberg Law, IP Attorneys Examine Bringing Trademark Law into the Dot-Com Age (June 4, 2020)
Life Sciences Compliance Attorneys Examine CARES Act OTC Drug Framework Overhaul (June 2, 2020)
In Bloomberg Law, Valerie Bonham Examines University Research Data Cybersecurity Risks (May 21, 2020)
In Law360, Ed McNicholas and Kelsey McIntosh Analyze COVID-19 Consumer Data Protection Act (May 18, 2020)
In Law360, IP Litigators Examine Federal Circuit Ruling Addressing Color Trade Dress Distinctiveness (May 12, 2020)
In Bloomberg Law, Peter Brody Analyzes Complexities of SCOTUS Ruling on Georgia Copyright Doctrine (May 5, 2020)
In Bloomberg Law, Marta Belcher Examines SCOTUS Ruling on States’ Copyright Doctrine (April 29, 2020)
In MedTech Dive, Kellie Combs Examines FDA Guidance on Digital Health Devices for Treating Psychiatric Disorders (April 28, 2020)
In Law360, Health Care Attorneys Analyze How to Determine Eligibility for U.S. Health and Human Services COVID-19 Emergency Funds (April 27, 2020)
In Law360, Health Care Attorneys Examine COVID-19 Actions on Health Workers Staffing Shortage (April 15, 2020)
IP Litigators Address How PREP Act May Fight Coronavirus-Related Patent Infringement Claims (April 10, 2020)
In Bloomberg News, Matt Rizzolo Examines COVID-19 IP Rights for New Tests and Treatments (April 10, 2020)
IP Litigators Address Challenges in Quantifying 5G Benefits and SEP Value (April 10, 2020)
In Law360, FDA Regulatory Attorneys Examine How COVID-19 May Spur Passage of Lab Test Reform Legislation (April 8, 2020)
In Forbes, Keith Higgins Analyzes SEC Safe Harbor Proposal for Cryptocurrencies (April 3, 2020)
IP Litigators Address Potential for COVID-19 U.S. Government-Authorized Patent Infringement (April 3, 2020)
In Bloomberg Law, Tom Bulleit Discusses COVID-19 Federal Health Regulation Changes (April 1, 2020)
In Law360, Tom Bulleit Addresses Impact of COVID-19 Relief Bill on Drug Pricing Legislation (March 30, 2020)
IP Litigator Matt Rizzolo Discusses Federal Circuit Ruling on PTAB Appointments (March 25, 2020)
In Pink Sheet Articles, Life Sciences Attorneys Examine New FDA Provisions for Biosimilars (March 25, 2020)
In Chemical & Engineering News, Valerie Bonham Examines Foreign Influence in Federal Research (March 24, 2020)
Greg Levine Navigates Coronavirus Lab Test Developer Through Novel FDA Process (March 18, 2020)
In The Chicago Tribune, Deborah Gersh Addresses Privacy Rules and Coronavirus Patient Identification (March 18, 2020)
Federal Circuit Affirms IPR Win for Multi Packaging Solutions (March 17, 2020)
In AHLA Connections Magazine, Valerie Bonham and Mark Barnes Examine Foreign Influence in Federally-Funded Research (March 11, 2020)
In Law360, IP Litigators Examine Patent Damages for Willful Blindness (March 3, 2020)
In Report on Medicare Compliance, Valerie Bonham Discusses Increased Scrutiny in Foreign Research Funding (March 3, 2020)
In Forbes, Keith Higgins Addresses SEC Proposed Changes to Accredited Investor Designation (January 22, 2020)
In Law360, Tom Bulleit and Scott Falin Recap 2019 Drug Pricing Initiatives and Look at 2020 (January 15, 2020)
IP Litigators Examine Patent Legislation to Watch in 2020 (January 6, 2020)
In Bloomberg Law, Health Care Attorney Addresses Delay in Harmonizing Human Research Rules (December 16, 2019)
In The New York Times, Douglas Hallward-Driemeier Examines Hospital Groups Lawsuit to Block Price-Transparency Rule (December 6, 2019)
In Reuters, IP Litigator Examines How Congressional Legislation Can Fix PTAB’s Appointments Clause (December 3, 2019)
In Healthcare Risk Management, Health Care Partner Addresses Proposed “Value-Based” Changes to Stark and Anti-kickback Regulations (November 25, 2019)
In Report on Research Compliance, Valerie Bonham Addresses Foreign Influence in Federal Grant Funding (October 17, 2019)
In MedTech Dive, Greg Levine Addresses FDA Guidance on Regulating Clinical Decision Support Software (October 2, 2019)
In Law360, IP Litigator Examines PTAB Estoppel Provision Splits in District Courts (September 5, 2019)
Cross-Practice Attorneys Examine What Self-Disclosure Guidance Means for Federal Research Awardees (August 8, 2019)
Health Care Partner Discusses Hospital Price Transparency Proposal (August 6, 2019)
IP Litigator Examines Federal Circuit Ruling on Constitutionality of Patents Issued Before the America Invents Act (August 1, 2019)
In Bloomberg Law, Health Care Partner Discusses Legal Challenges Facing Trump Administration’s International Drug Pricing Plan (July 15, 2019)
IP Litigator Examines Mid-Year Patent Cases and U.S. Congress Patent Bill in Law360 and Bloomberg Law (July 10, 2019)
In Law360, Health Care Attorneys Examine New CMS Bundled Payments Program (June 4, 2019)
In Law360, Cross-Practice Team Examines Federal Circuit Decision in International Trade Dispute on False Advertising Claims (May 15, 2019)
In Bloomberg Law, Health Care Partner Examines Final Rule on Drugmaker TV Ad Price Disclosures (May 14, 2019)
In Law360, Life Sciences Attorneys Examine FDA Draft Guidance on Medical Device Inspections (May 13, 2019)
IP Litigator Examines Federal Circuit Ruling in Trade Fight Over False Advertising Claims (May 3, 2019)
IP Attorneys Author IP Litigator Article on U.S. Supreme Court Decision on “On Sale” Bar in Drug Patent Case (April 23, 2019)
Asset Management Partner Nathan Briggs Quoted in Reuters on SEC Regulatory Proposal for Closed-End Funds (April 18, 2019)
Reg BI Establishes Higher Standards for Broker-Dealers, Asset Management Counsel David Tittsworth States in Pensions & Investments (April 16, 2019)
Law360 Quotes Asset Management Partner Mark Nuccio on OMB Memo Regarding White House Regulatory Reviews (April 15, 2019)
In Pink Sheet, Life Sciences Partner Discusses Drug Pre-Approval Promotion (March 28, 2019)
In Law360, IP Litigator Examines PTAB Motion to Amend Pilot Program (March 20, 2019)
IP Litigator Discussed the PTAB’s New Amendment Pilot in PLI Webinar (March 18, 2019)
IP Litigator Examines PTO’s New Precedent for Amending Patent Claims (March 13, 2019)
In Bloomberg Law, Health Care Partner Addresses Pay-for-Delay Drug Deals (March 13, 2019)
In Medical Marketing & Media, Attorneys Discuss Drug Pricing Proposals Before Congress (March 5, 2019)
In Law360, Health Care Attorneys Look at HHS Health Technology Policy Rules (February 25, 2019)
In Law360, Health Care Attorneys Examine Broader HHS Vision to Innovate Care Models (February 22, 2019)
In Bloomberg Law, IP Litigator Discusses U.S. Supreme Court AIA Case (February 15, 2019)
Ropes & Gray Attorneys Discuss the Government Shutdown’s Impact on the Asset Management Industry (February 4, 2019)
Health Care Partner Discusses HHS Secretary’s First Year in Office (January 31, 2018)
In Law360, IP Litigators Highlight Recent ITC-Related Federal Circuit Appeal (January 30, 2018)
Asset Management Counsel David Tittsworth Discusses State-By-State Fiduciary Approach in IFLR (January 26, 2019)
IP Litigator Quoted on U.S. Supreme Court Drug Patent Case Decision (January 24, 2018)
In Law360, Cross-Practice Team Analyzes What is New in Federal and State Drug Pricing Initiatives (January 15, 2019)
IP Litigator Examines New USPTO Patent Eligibility Guidance (January 8, 2019)
In Law360, IP Litigator Addresses Government Shutdown Impact on USPTO (January 4, 2019)
In Compliance Reporter, Management Counsel David Tittsworth Discusses Rep. Maxine Waters’ Nomination to Chair the House Financial Services Committee (December 11, 2018)
In Inside Health Policy, Health Care Partner Discusses Expected Rule on PBM Drug Rebates and Safe Harbors (December 11, 2018)
In Law360, Life Sciences Attorneys Address Proposed FDA Drug Software Rules (December 11, 2018)
Health Care Attorneys Author Law360 Article on CMS Final Medicare Rules for Outpatient Payment Cost-Cutting (November 30, 2018)
In The New York Times, IP Litigator Addresses the Use of Trademark Law in Motorcycle Club Racketeering Trial (November 27, 2018)
In FundFire Investment Management Counsel David Tittsworth Discusses House Committee on Financial Services (November 21, 2018)
Investment Management Counsel David Tittsworth Discusses the Midterm Election Results in Relation to Asset Management Priorities in Compliance Reporter (November 13, 2018)
IP Litigators Examine How Next U.S. Congress Might Impact Patent Law (November 7, 2018)
In Bloomberg Law, Health Care Partner Discusses Data Integrity in Shift to Value-Based Health Care Reimbursement (October 30, 2018)
Health Care Co-Chair Discusses HIPAA Audits Focused on Enforcement (October 30, 2018)
In Law360, Washington, D.C. Partners Analyze CMS’ Drug Price Disclosure Proposal (October 26, 2018)
In FundFire Investment Management Counsel David Tittsworth Discusses SEC Tech Focus to Modernization (October 17, 2018)
Bloomberg Law Publishes Article by Investment Management Counsel David Tittsworth Discussing SEC Staff Guidance (October 15, 2018)
In Life Sciences IP Review Article, IP Litigators Address ITC as Potentially Powerful Forum for Biologics Patent Owners (October 15, 2018)
Investment Management Counsel David Tittsworth Discusses Senate Action on Tax Reform in Compliance Reporter (October 5, 2018)
Investment Management Counsel David Tittsworth Discusses the SEC’s Consolidated Audit Trail and the ICI’s “2018 Evolution Revolution” in ACA Insight (September 18, 2018)
IP Litigator Examines Revised Procedures at the PTAB in The National Law Journal and Law360 (September 25, 2018)
In Bloomberg Law, Health Care Attorneys Analyze Proposed Medicare Shared Savings Program Overhaul (September 12, 2018)
The Wall Street Journal Quotes Investment Management Counsel David Tittsworth (September 5, 2018)
BoardIQ Quotes Investment Management Counsel David Tittsworth on Derivatives Rule Re-Proposal (August 28, 2018)
Investment Management Counsel David Tittsworth Quoted in ACA Insight on SEC Transparency Efforts (August 27, 2018)
Investment Management Counsel David Tittsworth Discusses the SEC’s Best Interest Proposals Ahead of the Comment Period’s Close in Ignites and Fund Action (August 27, 2018)
In Law360, Investment Management Counsel David Tittsworth Provides an Update on the SEC’s Evolving Asset Management Agenda (August 23, 2018)
Wolters Kluwer Publishes Two Articles Co-Authored by Ropes & Gray Asset Management Attorneys (August 23, 2018)
In Pensions & Investments Investment Management Counsel Weighs in on SCOTUS and SEC Nominees (August 23, 2018)
PTAB Chair Examines Revisions to America Invents Act Guidelines (August 15, 2018)
IP Litigator Examines Federal Circuit Ruling on Legal Fees and Statutory Interpretation in Bloomberg Law and Law360 (July 31, 2018)
Health Care Partner Addresses FDA Bid to Lower Drug Prices in The Washington Post (July 19, 2018)
In Pensions & Investments, Investment Management Counsel Discusses SCOTUS Nominee’s Challenges to Precedent on Deference to Regulators (July 17, 2018)
IP Litigation Counsel Address U.S. Supreme Court Decision on Overseas Patent Damages (June 27, 2018)
In Law360, Attorneys Examine FDA Final Guidance on Payor Communications and Communications Consistent with Labeling (June 27, 2018)
Investment Management Counsel Quoted in HFMWeek on Potential Return of SEC Derivatives Rule (June 21, 2018)
In Medical Marketing & Media, Life Sciences Partner Addresses Healthcare Marketing Changes Under Trump Administration (May 29, 2018)
In Law360, Life Sciences Attorneys Examine Lessons From FDA Draft Guidance on Multifunctional Devices (May 23, 2018)
Health Care Partner Analyzes President Trump’s Drug Pricing Speech (May 15, 2018)
IP Litigator Addresses PTAB Claim Construction Change (May 14, 2018)
In Law360, IP Litigator Writes About Possible Future “Patent Takings” Claims After U.S. Supreme Court’s Oil States Case (May 4, 2018)
IP Litigators Examine Two U.S. Supreme Court Patent Case Decisions (April 26, 2018)
IP Litigator Examines US Supreme Court’s Oral Arguments in Foreign Patent Damages Case (April 18, 2018)
In Bloomberg Law, IP Litigator Addresses Potential Procedural Changes to District Court Patent Eligibility Challenges (April 12, 2018)
IP Litigators Address Key PTAB Issues in Law.com (April 2, 2018)
Boston Health Care Partner Quoted in Report on Research Compliance Article (March 21, 2018)
In Bloomberg Law, PTAB Chair Examines Post-Grant Review Proceedings in Drug Patent Litigation (March 20, 2018)
Investment Management Counsel David Tittsworth Quoted In FundFire On Deregulation Legislation (March 14, 2018)
PTAB Chair Quoted in Intellectual Asset Management on Sovereign Immunity Decision (March 2, 2018)
In Law360, IP Litigator Addresses Sovereign Immunity (February 26, 2018)
In Law360, IP Litigator Addresses Federal Circuit Ruling on Patent Eligibility (February 15, 2018)
Health Care Attorneys Author Law360 Article on DOJ Guidance Limits in Civil Enforcement Matters (February 12, 2018)
In Investment Advisor/Think Advisor, Investment Management Counsel David Tittsworth Addresses Complications for the SEC’s Fiduciary Rule (February 1, 2018)
In Bloomberg Big Law Business, IP Litigator Examines TC Heartland Patent Venue Decision (January 31, 2018)
In Law360, IP Litigator Addresses U.S. Supreme Court Case on Overseas Patent Infringement Damages (January 23, 2018)
In Law360, Washington Health Care Partner Addresses Patient Assistance Program Lawsuit (January 12, 2018)
PTAB Chair Addresses Full Federal Circuit IPR One-Year Time-Bar Decision (January 10, 2018)
In Corporate Counsel, PTAB Chair Addresses Top 2018 IP Concerns for In-House Counsel (January 8, 2018)
Intellectual Property Litigator Quoted in Law.com on State Sovereign Immunity (January 4, 2018)
In Law360, IP Litigators Examine 2018 Patent Litigation Trends to Watch (January 3, 2018)
Intellectual Property Litigators Quoted in Reuters, Bloomberg BNA and Law360 on State Sovereign Immunity (December 22, 2017)
In Law360, Life Sciences and Corporate Team Examines FDA Move to Limit Digital Software Regulations (December 22, 2017)
In CBS MoneyWatch, Healthcare Partner Quoted on Navigating Obamacare Open Enrollment (December 13, 2017)
Washington Health Care Partner Authors Ninth Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (December 7, 2017)
Supreme Court Searches for Fourth Amendment Line for the Digital Economy (December 6, 2017)
Rosenstein Announces Permanent FCPA “Pilot Program,” Presumption of Declination When Self-Reporting, but Difficult Choices Remain (December 5)
IRS Notice Provides Guidance on Use of Donor Advised Funds for Pledges and Charity Events (December 5, 2017)
New Burma Act Would Hinder US Investment In Myanmar (December 4, 2017)
Ropes & Gray Names Alexandre Rene as Head of its Washington, D.C. Office (November 29, 2017)
Ropes & Gray Partners with the CFA Society For a Discussion on What to Expect From the New SEC (November 28, 2017)
New Cuba Sanctions Signal Increased Commercial Challenges (November 10, 2017)
SEC Issues No-Action Letters to Ease U.S. and MiFID II Compliance; EC Issues Guidance on MiFID II Advisers’ Receipt of Research from Non-EU Brokers(November 9, 2017)
Ropes & Gray Investment Management Counsel Comments on the SEC’s Data breach in ACA Insight (November 7, 2017)
At ACA's 2017 Fall Compliance Conference, Investment Management Counsel Discusses the Impact of Politics on Investment Adviser Industry (November 7, 2017)
Trending Video: FTC’s Merger Remedies Study (November 3, 2017)
Q&A: What to Expect from the “New” SEC (November 1, 2017)
In ACA Insight, Ropes & Gray Investment Management Counsel Discusses Key Issues for the SEC and the Commissioner Nominees (October 31, 2017)
Investment Management Counsel Provides Opening Address at the NRS Fall 2017 Compliance Conference (October 31, 2017)
In CBS MoneyWatch, Health Care Partner Discusses Navigating Obamacare Open Enrollment (October 30, 2017)
Investment Management Partner Widely Quoted in Asset Management Media on Cybersecurity at the SEC (October 24, 2017)
Cryptocurrency Update: CFTC Reaffirms Jurisdiction Over Certain Virtual Currency Transactions (October 19, 2017)
Health Care Partner Authors Eighth Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (October 19, 2017)
SEC Issues Guidance on Non-GAAP Financial Measures in Business Combination Projections (October 18, 2017)
SEC Proposes Amendments to Modernize and Simplify Regulation S-K (October 16, 2017)
Health Care Attorneys Author Law360 Article on Future of Value-Based Health Care (October 5, 2017)
Health Care Partner Quoted in Law360 on Latest Obamacare Repeal Failure (September 26, 2017)
Health Care Partner Authors Seventh Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (September 22, 2017)
Health Care Attorneys Author Law360 Article on Health Care Providers Becoming Payors (September 21, 2017)
Bloomberg BNA, InvestmentNews and Fund Action Quote Investment Management Counsel Investment Management Counsel on SEC Commissioner Nominees and Leadership (September 19, 2017)
Investment management counsel quoted in InvestmentNews, Fund Directions, Ignites and Law360 on business continuity planning (September 18, 2017)
OIG's Warranty Safe Harbor Opinion And Value-Based Care (September 15, 2017)
Health Care Partner Authors Sixth Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (August 10, 2017)
Health Care Partner Quoted in Law360 on Next Steps After Obamacare Repeal Failure (July 31, 2017)
Intellectual Property Litigator Addresses Impact of U.S. Senate’s STRONGER Patents Act in Inside Counsel (July 25, 2017)
Health Care Partners Fifth Column on “Repeal and Replace” for Series in Bloomberg BNA’s Health Law Reporter Addresses Legislative Challenge of Building Bipartisan Bill to Repair Obamacare (July 21, 2017)
Health Care Partner Quoted in Law360 on Expectations for Obamacare Repeal in U.S. Senate (July 11, 2017)
Tax & Benefits Attorney Discusses the DOL’s Request for Information on the Fiduciary Rule (July 11, 2017)
Health Care Partner Addresses U.S. Health Care Reform on CBS Radio (June 29, 2017)
Health Care Partner Quoted in Modern Healthcare and Bloomberg BNA on U.S. Senate’s Health Care Draft Bill (June 23, 2017)
Searching for Goldilocks: Five Takeaways From the Senate's Health-Care Reform Porridge-Making (June 22, 2017)
Investment Management Counsel Provides Insights on the Financial Choice Act in WSJ Pro PE, InvestmentNews, Compliance Week, and FundFire (June 19, 2017)
In InvestmentNews’ “Fiduciary Focus” Podcast, Ropes & Gray Tax & Benefits Attorney Discusses the Next Phase of The Fiduciary Rule’s Rollout (June 13, 2017)
In The Hedge Fund Law Report, Investment Management Counsel Provides Insights on The Financial CHOICE Act of 2017 (June 5, 2017)
Health Care Partner Quoted in Law360 on Republican Legislation to Repeal Obamacare (May 30, 2017)
Health Care Partner Quoted in CBS MoneyWatch on Congressional Budget Office Analysis of Republican Health Care Bill (May 26, 2017)
In ACA Insight, Investment Management Counsel Discusses Priorities for New SEC Chairman Jay Clayton (May 12, 2017)
Health Care Partner Quoted in National Law Journal on Guidance for Legal Counsel After Passage of AHCA (May 8, 2017)
Investment Management Counsel Authors Article Examining President Trump’s Executive Orders Relating to the Financial Services Industry (May 5, 2017)
Buyouts Quotes Ropes & Gray tax partner on President Trump's Tax-Reform Proposal (May 5, 2017)
“Reports of the AHCA's Revival: Will Giving the States Obamacare Waivers Thread the Needle?” Bloomberg BNA's Health Law Report (April 27, 2017)
Health Care Partner Examines MacArthur Amendment to the American Health Care Act in Bloomberg BNA (April 27, 2017)
“Failure to Launch the American Health Care Act: Portents for the Future of Health Care Reform?” Bloomberg BNA's Health Law Report (April 6, 2017)
Law360 quotes health care partner Deb Gersh on Trump's HHS Fast To Grant Industry Wishes (March 20, 2017)
Law360 quotes government enforcement partner Nick Berg on Obama-Era rules (March 10, 2017)
Bloomberg BNA Health Care Daily Report Quotes Health Care Partner Thomas Bulleit on the GOP Health Plan (March 8, 2017)
Investment Management Counsel Quoted Extensively on Proposed Fiduciary Rule Delay (March 6, 2017)
“The Price of TrumpCare: Five Takeaways From the HHS Secretary and Other Republican Proposals,” Bloomberg BNA's Health Law Report (February 23, 2017)
In National Law Journal Health Care Partner Discusses ACA Repeal (February 15, 2017)
In Hedge Fund Legal & Compliance Digest Ropes & Gray Attorneys Discuss the SEC Under President Trum‎p (February 9, 2017)
Bloomberberg BNA Health Law Reporter Quotes Health Care Partner Mark Barnes on Trump Travel Ban, Bloomberg BNA's Health Care Daily Report (February 2, 2017)
“Trump's '2-for-1' regulation order seems straightforward, but it isn't,” The Business Journals (January 31, 2017)
“Trump order targeting business rules leaves key regulations untouched,” Reuters (January 30, 2017)
“Trump’s latest executive order targets and caps new regulations,” FierceHealthcare (January 30, 2017)
Bloomberg BNA Health Law Reporter Quotes Health Care Partner Tom Bulleit on Obamacare Executive Order Bloomberg BNA's Health Care Daily Report
(January 26, 2017)
Investment Management Counsel: “The World According to Trump” (January 19, 2017)
“White House Finalizes Scaled Back Research Regs,” Health Care Daily Report (January 18, 2017)
Health Care and FDA Changes Expected Under Trump Administration (January 11, 2017)
“The New U.S. Department of Health and Human Services: Tom Price and Value-Based Health Care,” JD Supra Business Advisor (January 6, 2017)
“The New FDA: Product Development, Pricing and Beyond,” JD Supra Business Advisor (January 6, 2017)
“Life Sciences Legislation and Regulation to Watch In 2017,” Law360 (January 2, 2017)
“GOP Repeal-And-Delay Plans Spell Uncertainty For Insurers,”HealthcareDIVE (December 14, 2016)
“Tax & Benefits Counsel Discusses Trump’s Potential Impact on Charitable Giving in Bloomberg BNA’s Daily Tax Report,” (December 14, 2016)
“Trump Administration Could End Need for ACA Appeal, House Republicans Say,” Bloomberg BNA Health Law Reporter (December 1, 2016)
“In Reuters, Investment Management Partner Discusses the Future of the Volcker Rule Under the Trump Administration (November 30, 2016)
“In Ignites and Fund Board Views, Investment Management Counsel Discusses the Future of FSOC and the Derivatives Rule Under a New President and New SEC Chair”(November 30, 2016)
“Health Care Partner Quoted in Life Sciences Law & Industry News Article on the Obama Administration Trying to Release a Major Revision to the Common Rule Before Inauguration Day,” Bloomberg BNA Life Sciences & Industry Report (November 18, 2016)
“Obamacare Cases in Limbo Following Republican Wins in White House, Congress,” Bloomberg BNA Health Law Reporter (November 17, 2016)
“Life Sciences Partner Quoted in Bloomberg BNA’s Health Care Daily Report on Drug Industry Facing Less Scrutiny Under President Trump and the New U.S. Congress,” (November 15, 2016)
“Private Client Group Partner Quoted in The New York Times on Tax Policy under President-elect Trump,” (November 14, 2016)
“Republicans Face Divisions over ObamaCare Repeal,” The Hill (November 13, 2016)
“Experts Struggle to Predict How Trump Will Use Sanctions,”The Wall Street Journal (November 11, 2016)
“How GCs Should Prepare for Trump's ACA Repeal,” Corporate Counsel (November 11, 2016)
“Trumping Obamacare: Some Likely Effects of the Election on Health Care,” (November 10, 2016)
“In Health Care Daily Report, Health Care and Life Sciences Partners Discuss the Drug Pricing Under Trump,” Health Care Daily Report (November 10, 2016)
“Iran-Deal Sanctions Relief Could Be Overturned With ‘Stroke of a Pen,” Wall Street Journal (November 9, 2016)
“Bye-bye Dodd-Frank? What Donald Trump's win means for the banking red tape,” City A.M. (November 9, 2016)
“In Law360, Health Care Partner Reacts to Trump's Election To The White House,” Law360 (November 9, 2016)
“Trump's Victory Will Reshape Financial Rules, Supreme Court,”The National Law Journal (November 9, 2016)

In The News